Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-07 · accession 0001062993-24-012312 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | 2024-06-07 | IPSC | Carr Douglas | SVP Fin, Ops | A - Grant | $0.00 | +17.0K | 334.3K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-07 | A | A | 17,007 | $0.00 | 334,330 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 100% on June 7, 2025, subject the Reporting Person's continued service through such vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. |